Veracyte, Inc. (VCYT)
44.06
+2.59
(+6.25%)
USD |
NASDAQ |
Aug 25, 16:00
44.06
0.00 (0.00%)
After-Hours: 19:59
Veracyte Profit Margin (Quarterly) : 16.96% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 16.96% |
| March 31, 2026 | 20.64% |
| December 31, 2025 | 29.26% |
| September 30, 2025 | 14.51% |
| June 30, 2025 | -0.75% |
| March 31, 2025 | 6.16% |
| December 31, 2024 | 4.31% |
| September 30, 2024 | 13.08% |
| June 30, 2024 | 5.01% |
| March 31, 2024 | -1.92% |
| December 31, 2023 | -28.81% |
| September 30, 2023 | -32.87% |
| June 30, 2023 | -9.30% |
| March 31, 2023 | -9.82% |
| December 31, 2022 | -4.79% |
| September 30, 2022 | -11.54% |
| June 30, 2022 | -13.08% |
| March 31, 2022 | -21.33% |
| December 31, 2021 | -15.64% |
| September 30, 2021 | -23.40% |
| June 30, 2021 | -16.40% |
| March 31, 2021 | -114.1% |
| December 31, 2020 | -23.29% |
| September 30, 2020 | -13.25% |
| June 30, 2020 | -53.25% |
| Date | Value |
|---|---|
| March 31, 2020 | -37.65% |
| December 31, 2019 | -25.09% |
| September 30, 2019 | -2.36% |
| June 30, 2019 | -8.28% |
| March 31, 2019 | -6.49% |
| December 31, 2018 | -12.06% |
| September 30, 2018 | -19.04% |
| June 30, 2018 | -27.46% |
| March 31, 2018 | -45.79% |
| December 31, 2017 | -43.06% |
| September 30, 2017 | -40.24% |
| June 30, 2017 | -39.65% |
| March 31, 2017 | -50.01% |
| December 31, 2016 | -24.12% |
| September 30, 2016 | -30.30% |
| June 30, 2016 | -76.61% |
| March 31, 2016 | -74.35% |
| December 31, 2015 | -57.06% |
| September 30, 2015 | -72.52% |
| June 30, 2015 | -76.72% |
| March 31, 2015 | -67.84% |
| December 31, 2014 | -66.74% |
| September 30, 2014 | -80.32% |
| June 30, 2014 | -76.70% |
| March 31, 2014 | -89.27% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Globus Medical, Inc. | 19.20% |
| Recursion Pharmaceuticals, Inc. | -1.71K% |
| Anika Therapeutics, Inc. | 10.15% |
| Perspective Therapeutics, Inc. | -33.31K% |
| Teleflex, Inc. | 7.32% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 8.78% |
| Return on Assets | 8.09% |
| Return on Invested Capital | 8.50% |
| Gross Profit Margin (Quarterly) | 71.93% |
| Operating Margin (Quarterly) | 15.89% |
| Return on Net Operating Assets | 11.60% |